Showing results for 'E'
Total number of hits: 34
Click on results for more details:
PDIDA002
AC1L9V0Z
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDC095
ClNH3MeCOO Echinocandin
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDA003
AC1L9V12
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDA004
AC1L9V15
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDD024
Dipivefrine
Active compound: Epinephrine
Indications: Open-angle glaucoma
Target: Adrenergic receptor
PDIDE003
Enalapril
Active compound: Enalaprilat
Indications: Hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction
Target: Angiotensin-converting-enzyme inhibitor
PDIDE005
Epirubicin-glucuronide
Active compound: Epirubicin
Indications: Cancer
Target: Topoisomerase II
PDIDE006
Erythromycin acetate
Active compound: Erythromycin
Indications: Respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis
Target: 23S ribosomal RNA molecule in the 50S subunit of ribosomes
PDIDE007
Erythromycin ethylsuccinate
Active compound: Erythromycin A
Indications: Respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis
Target: 23S ribosomal RNA molecule in the 50S subunit of ribosomes
PDIDE008
Erythromycin propionate
Active compound: Erythromycin
Indications: Respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis
Target: 23S ribosomal RNA molecule in the 50S subunit of ribosomes
PDIDE009
Eslicarbazepine acetate
Active compound: Eslicarbazepine
Indications: Partial-onset seizures
Target: P2X purinoceptor 4
PDIDE011
Estradiol acetate
Active compound: Estradiol
Indications: Vasomotor and urogenital symptoms associated with menopause
Target: Estrogen Receptor (ER) including ERα and ERβ subtypes
PDIDE012
Estradiol benzoate
Active compound: Estradiol
Indications: Terminate pregnancy; Menstrual disorder; Prostate cancer
Target: Estrogen Receptor (ER) including ERα and ERβ subtypes
PDIDE013
Estradiol cypionate
Active compound: Estradiol
Indications: Moderate to severe vasomotor symptoms associated with menopause; Hypoestrogenism due to hypogonadism
Target: Estrogen Receptor (ER) including ERα and ERβ subtypes; NR3A (ESR)(KEGG)
PDIDE014
Estradiol enanthate
Active compound: Estradiol
Indications: Contraceptive for women
Target: Estrogen Receptor (ER)
PDIDE015
Estradiol glucuronide
Active compound: Estradiol
Indications: Contraceptive for women
Target: Estrogen Receptor (ER)
PDIDE016
Estradiol undecylate
Active compound: Estradiol
Indications: Prostate cancer
Target: Estrogen receptor beta; Estrogen receptor alpha
PDIDE018
Estramustine phosphate
Active compound: Estramustine
Indications: Prostate cancer
Target: Tubulin beta
PDIDE019
Estriol glucuronide
Active compound: Estriol
Indications: Na
Target: na
PDIDE020
Estriol sulfate glucuronide
Active compound: Estriol
Indications: Na
Target: na
PDIDF026
Frueh_etal_2017_ELQ-331
Active compound: ELQ-300
Indications: Malaria
Target: Plasmodium falciparum cytochrome bc1 complex
PDIDH007
HOOCEtNHCOO Echinocandin
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDH008
HOOCMeNHCOO Echinocandin
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDH009
HOOCMeNMeCOO Echinocardin
Active compound: Echinocandin B
Indications: Pneumocystis carinii pneumonia
Target: na
PDIDM007
Mepitiostane
Active compound: Epitiostanol
Indications: Breast cancer
Target: Estrogen receptor alpha; Estrogen receptor beta
PDIDM011
Mestranol
Active compound: Ethinyl estradiol
Indications: Oral contraceptives
Target: Estrogen receptor alpha (WL1, WL2); estrogen receptor beta (WL2)
PDIDN009
Nilestriol
Active compound: Ethinylestriol
Indications: Post-menopausal Osteoporosis
Target: Androgen receptor
PDIDP020
Polyestradiol phosphate
Active compound: Estradiol
Indications: Prostatic cancer
Target: Estrogen receptor alpha
PDIDR007
RB150
Active compound: EC33
Indications: Blood Pressure
Target: Aminopeptidase A (APA)
PDIDS013
SCHEMBL18396052
Active compound: ELQ-300
Indications: Malaria
Target: Plasmodium falciparum cytochrome bc1 complex
PDIDS022
SCHEMBL4047434
Active compound: Eniluracil
Indications: liver, lung, adrenal, testis, and prostate cancers
Target: Mechanism-based inhibitor of dihy-dropyrimidine dehydrogenase (DPD)
PDIDS023
SCHEMBL4809664
Active compound: Eglumetad
Indications: Psychosis, anxiety, anddrug withdrawal
Target: Group II metabotropic glutamate (mGlu) receptors
PDIDT006
Tamoxifen
Active compound: Endoxifen
Indications: Breast cancer
Target: Estrogen receptor
PDIDA038
Alestramustine
Active compound: Estramustine
Indications: Metastatic and/or progressive carcinoma of the prostate
Target: Microtubule-associated proteins and β-tubulin